Levetiracetam Actavis

Levetiracetam, the active ingredient in Levetiracetam Actavis, is an anticonvulsant presented as an oral tablet for systemic use. It is prescribed to manage various seizure types in patients with epilepsy, including partial, generalized tonic‑clonic, and myoclonic seizures, and is administered under medical supervision.

GNH USA supplies Levetiracetam Actavis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and regulatory requirements to ensure product integrity across global markets.

Levetiracetam is an anticonvulsant used to treat seizure disorders.

- Partial seizures: reduces the frequency of focal onset seizures. - Generalized tonic‑clonic seizures: helps control convulsive episodes. - Myoclonic seizures: decreases the occurrence of rapid muscle jerks.

Levetiracetam may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness: transient sensation of light‑headedness. - Fatigue: feeling unusually tired or weak. - Headache: mild to moderate cranial pain. - Irritability: increased emotional sensitivity. - Nausea: occasional stomach upset. - Nasal congestion: mild blockage of nasal passages.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Mood changes: depression, anxiety, or suicidal thoughts. - Hematologic abnormalities: low blood cell counts. - Hepatic dysfunction: elevated liver enzymes. - Stevens‑Johnson syndrome: severe skin blistering. - Multi‑organ failure: rare systemic involvement.

Before initiating therapy, consider the following safety measures.

- Renal impairment: adjust dose as needed based on kidney function. - Hepatic disease: monitor liver function tests regularly. - Psychiatric symptoms: observe for mood changes or suicidal ideation. - Concomitant enzyme‑inducing antiepileptics: may reduce levetiracetam efficacy. - Pregnancy: use only if potential benefit outweighs unknown risk. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Levetiracetam can interact with several medications, requiring careful management.

Major Interactions (Avoid): - Carbamazepine: may decrease levetiracetam plasma concentrations. - Phenytoin: can reduce levetiracetam efficacy. - Phenobarbital: may lower levetiracetam levels.

Moderate Interactions (Monitor Closely): - Alcohol: may enhance central nervous system depression. - Other antiepileptic drugs: monitor seizure control and adjust doses as needed. - Renal excretion inhibitors: may increase levetiracetam exposure, requiring dose review.